These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3175314)

  • 61. Importance of trends in the interpretation of an overall odds ratio in the meta-analysis of clinical trials.
    Senn S
    Stat Med; 1994 Feb; 13(3):293-6. PubMed ID: 8202653
    [No Abstract]   [Full Text] [Related]  

  • 62. A simulation study of the validity and efficiency of design-adaptive allocation to two groups in the regression situation.
    Aickin M
    Int J Biostat; 2009 May; 5(1):Article 19. PubMed ID: 20224630
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Meta-analysis of pairs of survival curves under heterogeneity: a Poisson correlated gamma-frailty approach.
    Fiocco M; Putter H; van Houwelingen JC
    Stat Med; 2009 Dec; 28(30):3782-97. PubMed ID: 19899066
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Dropouts and missing data in psychiatric clinical trials.
    Potkin SG; Siu CO
    Am J Psychiatry; 2009 Nov; 166(11):1295; author reply 1295-6. PubMed ID: 19884237
    [No Abstract]   [Full Text] [Related]  

  • 65. Pitfalls in meta-analysis of observational studies: lessons from a systematic review of the risks of stenting for intracranial atherosclerosis.
    Trinquart L; Touzé E
    Stroke; 2009 Oct; 40(10):e586-7; author reply e590. PubMed ID: 19745174
    [No Abstract]   [Full Text] [Related]  

  • 66. Estimating reliability and generalizability from hierarchical biomedical data.
    Molenberghs G; Laenen A; Vangeneugden T
    J Biopharm Stat; 2007; 17(4):595-627. PubMed ID: 17613644
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Large trials vs meta-analysis of smaller trials.
    Klebanoff MA; Levine RJ; DerSimonian R
    JAMA; 1997 Feb; 277(5):376-7; author reply 377-8. PubMed ID: 9010166
    [No Abstract]   [Full Text] [Related]  

  • 68. Meta-analysis for 2 x 2 tables: a Bayesian approach.
    Carlin JB
    Stat Med; 1992 Jan; 11(2):141-58. PubMed ID: 1349763
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Exploring the relationship between the causal-inference and meta-analytic paradigms for the evaluation of surrogate endpoints.
    Van der Elst W; Molenberghs G; Alonso A
    Stat Med; 2016 Apr; 35(8):1281-98. PubMed ID: 26612787
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Reporting cumulative proportion of subjects with an adverse event based on data from multiple studies.
    Chuang-Stein C; Beltangady M
    Pharm Stat; 2011; 10(1):3-7. PubMed ID: 20073040
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [From a statistical standpoint].
    Nakazato H; Sakamoto J
    Gan To Kagaku Ryoho; 1991 Jul; 18(9):1517-25. PubMed ID: 1830199
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Advantages of meta-analysis of clinical trials].
    Boissel JP
    Therapie; 1994; 49(3):161-4. PubMed ID: 7878576
    [No Abstract]   [Full Text] [Related]  

  • 73. Clinical trial quality needs to be improved to facilitate metaanalyses.
    Chalmers TC
    Online J Curr Clin Trials; 1993 Sep; Doc No 89():[1541 words; 14 paragraphs]. PubMed ID: 8306015
    [No Abstract]   [Full Text] [Related]  

  • 74. Meta-regression approximations to reduce publication selection bias.
    Stanley TD; Doucouliagos H
    Res Synth Methods; 2014 Mar; 5(1):60-78. PubMed ID: 26054026
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [The meta-analysis of clinical studies: the philosopher's stone or a bone of contention?].
    Baumann M
    Strahlenther Onkol; 1999 Apr; 175 Suppl 1():17-20. PubMed ID: 10230453
    [No Abstract]   [Full Text] [Related]  

  • 76. Large trials vs meta-analysis of smaller trials.
    Johnson BT; Carey MP; Muellerleile PA
    JAMA; 1997 Feb; 277(5):377; author reply 377-8. PubMed ID: 9010167
    [No Abstract]   [Full Text] [Related]  

  • 77. Some problems with the investigation of noninferiority in meta-analysis.
    Witte S; Victor N
    Methods Inf Med; 2004; 43(5):470-4. PubMed ID: 15702203
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comments on 'An exploratory test for an excess of significant findings' by JPA loannidis and TA Trikalinos.
    Johnson V; Yuan Y
    Clin Trials; 2007; 4(3):254-5; discussion 256-7. PubMed ID: 17715250
    [No Abstract]   [Full Text] [Related]  

  • 79. [Clinical trials--what is the question?].
    Guttenberger R
    Med Klin (Munich); 1999 Apr; 94 Suppl 2():14-6. PubMed ID: 10740395
    [No Abstract]   [Full Text] [Related]  

  • 80. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses.
    Stang A
    Eur J Epidemiol; 2010 Sep; 25(9):603-5. PubMed ID: 20652370
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.